Stoke Therapeutics, Inc. (STOK)
36.73
+0.32
(+0.88%)
USD |
NASDAQ |
Mar 02, 16:00
36.45
-0.28
(-0.76%)
After-Hours: 20:00
Stoke Therapeutics EPS Diluted (Quarterly) : -0.6543 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Krystal Biotech, Inc. | 1.699 |
| Scholar Rock Holding Corp. | -0.8988 |
| Zymeworks, Inc. | -0.2587 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.35M |
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 48.98M |
| Enterprise Value | 1.836B |
| Gross Profit Margin (Quarterly) | 90.70% |
| Profit Margin (Quarterly) | -360.7% |
| Earnings Yield | 1.80% |
| Operating Earnings Yield | 1.27% |
| Normalized Earnings Yield | 1.797 |